Celyad Oncology SA

06/11/2021 | Press release | Distributed by Public on 06/11/2021 01:03

Celyad Oncology Presents Preliminary Data from Phase 1 IMMUNICY-1 Trial of shRNA-based Allogeneic CAR T Candidate CYAD-211 in Relapsed/Refractory Multiple Myeloma at the[...]